(Q44677541)

5 December 2017

title

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults (English)

1 reference

5 December 2017

main subject

United States of America

0 references

1 reference

Hoerger TJ

1

1 reference

5 December 2017

Bala MV

2

1 reference

5 December 2017

Bray JW

3

1 reference

5 December 2017

Wilcosky TC

4

1 reference

5 December 2017

LaRosa J

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

American Journal of Cardiology

5 December 2017

published in

1 reference

5 December 2017

volume

82

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

61-65

1 reference

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality. A 12-year follow-up of the Oslo Study, Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

Outcome monitoring of fluvastatin in a Department of Veterans Affairs Lipid Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900227-6

10.1016/S0002-9149(98)00227-6

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference